General Biologicals (ROCO:4117) Interest Expense : NT$-13.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is General Biologicals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. General Biologicals's interest expense for the six months ended in Dec. 2024 was NT$ -6.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-13.4 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. General Biologicals's Operating Income for the six months ended in Dec. 2024 was NT$ -117.4 Mil. General Biologicals's Interest Expense for the six months ended in Dec. 2024 was NT$ -6.8 Mil. General Biologicals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

General Biologicals Interest Expense Historical Data

The historical data trend for General Biologicals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

General Biologicals Interest Expense Chart

General Biologicals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-3.32

-11.00

-16.86

-11.98

-13.37

General Biologicals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial															-11.40	-6.12	-5.86	-6.59	-6.78

General Biologicals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-13.4 Mil.

General Biologicals (ROCO:4117) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

General Biologicals's Interest Expense for the six months ended in Dec. 2024 was NT$-6.8 Mil. Its Operating Income for the six months ended in Dec. 2024 was NT$-117.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was NT$2,100.9 Mil.

General Biologicals's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

General Biologicals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

General Biologicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » General Biologicals Corp (ROCO:4117) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No-6, Innovation First Road, Hsinchu Science Park, Hsinchu, TWN, 300092

Website

https://www.gbc.com.tw

General Biologicals Corp is a developer and manufacturer of vitro diagnostic devices in Taiwan. It offers research development, marketing and servicing of products and solutions for hospitals, medical laboratories, blood banks, and research and industry. Its products include Anti-HDV, HIV Ag-Ab COMB, Anti-HBs, and many others.

General Biologicals Headlines

No Headlines